Nemtabrutinib, Bortezomib, and Rituximab for WM
Clinical trial NCT07464210 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07464210
- Sponsor
- Seoul National University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-08-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.